As the complexity of patient care increases, so does the prevalence of polypharmacy, defined as the concurrent use of multiple medications by a patient. This phenomenon, while sometimes necessary, poses significant challenges due to potential drug-drug interactions (DDIs).
With the aging population and the rise in chronic diseases, polypharmacy has become commonplace. It is particularly prevalent among the elderly, where it is associated with increased morbidity and mortality, decreased physical and cognitive functioning, and a higher risk of hospitalization.
DDIs occur when the effect of one drug is altered by another. They can lead to decreased therapeutic efficacy or increased toxicity. The risk of DDIs exponentially increases with each additional medication, making polypharmacy a significant concern.
Healthcare professionals can employ several strategies to manage polypharmacy effectively. Regular medication reviews are crucial, focusing on the appropriateness of each drug. Deprescribing, the systematic process of identifying and discontinuing drugs in instances where existing or potential harms outweigh benefits, is also an important tool.
Modern healthcare technology can assist in managing polypharmacy. Electronic health records (EHRs) and clinical decision support systems (CDSS) can flag potential DDIs, aiding clinicians in prescribing decisions. However, these tools' effectiveness depends on their correct and consistent use.
Navigating the complex landscape of polypharmacy and DDIs is a crucial aspect of modern healthcare. Through proactive strategies like regular medication reviews and deprescribing, along with the effective use of technology, healthcare professionals can mitigate the risks associated with polypharmacy, enhancing patient safety and outcomes.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation